Christopher Viehbacher, a former Triangle resident and now chief executive officer at global pharmaceutical firm Sanofi, will be the keynote speaker at the Council for Entrepreneurial Development’s Life Science Conference in February.

Viehbacher, a former senior executive at GlaxoSmithKline, was very active in Triangle community affairs. He left GSK after losing out in a battle to become the company’s CEO with Andrew Witty.

The CED conference is set for Feb. 15-16 at the Raleigh Convention Center. It is one of the largest life sciences events in the southeast.

Chairs for the conference are Dr. Victor J. Dzau, chancellor for health affairs at Duke University and president and CEO of Duke University Health System, and Robert A. Ingram, general partner, Hatteras Venture Partners.

Other speakers include:

  • Alex Gorsky, vice chairman, Johnson & Johnson
  • Bill Hawkins, retired chairman and CEO, Medtronic, Inc.
  • Kris Jenner, vice president, T. Rowe Price Group
  • Jeremy Levin, senior vice president, strategy, alliances and transactions, Bristol-Myers Squib.

“This conference represents the largest gathering in the southeast of the region’s life science community,” said Joan Siefert Rose, CED’s president. “We are excited to present a top-tier line-up of speakers for this event, which showcases a robust industry for North Carolina.”

Partners with the CED for the event are the North Carolina Biotechnology Center and North Carolina Biosciences (NC BIO).

For registration information, click here.

Get the latest news alerts: Follow WRAL Tech Wire at Twitter.